Program Committee

Say “hello” to this year’s Program Committee!  ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to our in-person and virtual attendees.

Co-Chairs

Marcin Czech
Marcus Guardian
Chief Operating Officer, EUnetHTA, Amsterdam, Netherlands
Marcin Czech
Rui Santos Ivo
President, INFARMED, I.P., Lisbon, Portugal
Lotte Steuten
Tara Symonds, PhD
Principal Scientific Advisor, Clinical Outcome Assessments, Clinical Outcomes Solutions Ltd., England, UK
Lotte Steuten
Uwe Siebert, MD, MPH, MSc, ScD
Professor, UMIT - University for Health Sciences, Medical Informatics and Technology, Tirol, Austria and Harvard Chan School of Public Health, Boston, MA, US


Members

Bryan Bennett, PhD 
WWHEOR PRO Lead, Bristol Meyers-Squibb, England, United Kingdom


Roisin Adams
Head of HTA Strategy and External Engagement, NCPE, Dublin, Ireland


Imre Boncz, MD, MSc, PhD, Habil
Professor & Director, University of Pécs, Pécs, Hungary


Geneviève Bonnélye-Fesnien
Global Head of RWE Research & Consulting, Managing Director France, Cerner Enviza, Paris, France


Jacoline Bouvy, MSc, PhD
Technical Director, NICE Scientific Advice, NICE, London, United Kingdom


Thor-Henrik Brodtkorb, PhD
Executive Director, Health Economics, RTI Health Solutions, Ljungskile, Sweden


Claire Burbridge, MSc CPsychol
Executive Director, Clinical Outcome Assessments, Clinical Outcomes Solutions Ltd., Folkestone, UK


Brian Buysse, PhD
Syneos Health, Senior Director Epidemiology, Spain


Isaac Corro Ramos, MSc
Scientific Researcher, Institute for Medical Technology Assessment, The Netherlands


Bill Byrom, PhD
Vice President, Product Intelligence and Positioning, Signant Health, London, United Kingdom


Fleur Chandler, MSc
Head, Market Access UK and Ireland, Sanofi, England, United Kingdom


Isaac Corro Ramos, MSc, PhD
Scientific Researcher, Institute for Medical Technology Assessment, The Netherlands


Edith Frenoy
Director, Public Policy, Strategic Advocacy Lead, Merck, Brussels, Belgium


Koen Degeling, BSc, MSc, PhD
Research Scientist, Lumen Value & Access, The Netherlands


Mendwas (Mendy) Dzingina, MSc, PhD
Senior Director, HEOR Methods and Capabilities Lead, Pfizer, London, United Kingdom


Ramiro Eugenio Gilardino, MHA, MSc, MD
WWHEOR Advanced Scientific Capabilities, HTA Strategy & Affordability, Bristol Myers Squibb, Switzerland


Iñaki Imaz-Iglesia, MD, PhD, MPH
Researcher, Health Technology Assessment Agency, Institute of Health “Carlos III” (AETS-ISCIII), Madrid, Spain


Nicky Welton, PhD
Professor, Statistical and Health Economic Modelling, Director, NICE Guidelines Technical Support Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom


Saskia Knies, PhD
Senior Advisor, Cost-Effectiveness and Personalised Medicine, Coordinator, Research Network HTA National Health Care Institute, The Netherlands


Neda Milevska Kostova, BSc, MPP, MSc, PhD
Chair, International Alliance of Patients Organisations, United Kingdom


Laura McCullagh, PhD
Head of Research, Chief I Pharmacist, National Centre for Pharmacoeconomics Ireland (NCPE), Dublin, Ireland

Thomas Rapp, PhD
Associate Professor, Université Paris Cité (LIRAES), Co-director of the Health Policy Research Program, Sciences Po (LIEPP), Paris, France

 

Vanessa Schaub, PhD
Global Access Evidence Enabler HTA Strategy, F. Hoffmann La Roche, Basel, Switzerland



Praveen Thokala, MASc, PhD
Senior Research Fellow, School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, United Kingdom



Nicky J Welton, PhD
Professor, Statistical and Health Economic Modelling, Director, NICE Guidelines Technical Support Unit, co-Director, Bristol Technology Assessment Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom





Carme Pinyol, MD, PhD, MSc
Strategic Access Lead, Novartis, Barcelona, Spain 

 

 

Delphine Saragoussi, MSPH, MD
Executive Director, Research Science, Evidera, Paris, France
 

 

 

 

Anne Spencer
Professor, University of Exeter, Exeter, United Kingdom

 

 

Ian Watson
Senior Technical Adviser – Methods, NICE, London, United Kingdom


 

 

Sorrel Wolowacz, PhD
Head, European Health Economics, RTI Health Solutions, Manchester, United Kingdom